Phreesia, Inc. (PHR) Revenue History
Annual and quarterly revenue from 2018 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
PHR Revenue Growth
Revenue Breakdown (FY 2025)
PHR's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
PHR Revenue Analysis (2018–2025)
As of May 8, 2026, Phreesia, Inc. (PHR) generated trailing twelve-month (TTM) revenue of $463.2 million, reflecting strong growth of +12.7% year-over-year. The most recent quarter (Q3 2026) recorded $120.3 million in revenue, up 2.6% sequentially.
Looking at the longer-term picture, PHR's 5-year compound annual growth rate (CAGR) stands at +27.5%, indicating outstanding long-term growth trajectory. The company achieved its highest annual revenue of $419.8 million in 2025, representing a new all-time high.
Revenue diversification analysis shows PHR's business is primarily driven by Subscription And Services (47%), Network Solutions (29%), and Payment Processing Fees (24%).
When compared to Healthcare sector peers including HCAT (+1.5% YoY), DOCS (+15.9% YoY), and GDRX (-1.2% YoY), PHR has underperformed the peer group in terms of revenue growth. Compare PHR vs HCAT →
PHR Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| PHRCurrent | $463M | +12.7% | +27.5% | -13.8% | |
 HCAT | $311M | +1.5% | +10.5% | -51.7% | |
 DOCS | $570M | +15.9% | +37.4% | 39.9% | |
 GDRX | $797M | -1.2% | +7.7% | 13.4% | |
 VEEV | $3.2B | +16.3% | +16.9% | 28.7% | |
 INVA | $425M | +13.6% | +4.8% | 38.5% |
PHR Historical Revenue Data (2018–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $419.8M | +17.8% | $284.9M | 67.9% | $-58,097,000 | -13.8% |
| 2024 | $356.3M | +26.8% | $232.3M | 65.2% | $-136,479,000 | -38.3% |
| 2023 | $280.9M | +31.7% | $171.6M | 61.1% | $-176,552,000 | -62.8% |
| 2022 | $213.2M | +43.4% | $131.8M | 61.8% | $-116,817,000 | -54.8% |
| 2021 | $148.7M | +19.1% | $96.3M | 64.8% | $-25,671,000 | -17.3% |
| 2020 | $124.8M | +24.9% | $80.1M | 64.2% | $-15,298,000 | -12.3% |
| 2019 | $99.9M | +25.1% | $62.9M | 63.0% | $-9,493,676 | -9.5% |
| 2018 | $79.8M | - | $50.1M | 62.7% | $-14,553,000 | -18.2% |
See PHR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs PHR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare PHR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonPHR — Frequently Asked Questions
Quick answers to the most common questions about buying PHR stock.
Is PHR's revenue growth accelerating or slowing?
PHR maintains +12.7% revenue growth, in line with its 5-year CAGR of +27.5%. TTM revenue stands at $463M. Growth rate remains consistent with historical average.
What is PHR's long-term revenue growth rate?
Phreesia, Inc.'s 5-year revenue CAGR of +27.5% reflects the sustained expansion pattern. Current YoY growth of +12.7% is near this long-term average.
How is PHR's revenue distributed by segment?
PHR reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2018-2025 are available for download. Segment mix reveals concentration and diversification trends.